Year |
Citation |
Score |
2021 |
Naz S, Banerjee T, Totsingan F, Woody K, Gross RA, Santra S. Therapeutic Efficacy of Lactonic Sophorolipids: Nanoceria-Assisted Combination Therapy of NSCLC using HDAC and Hsp90 Inhibitors. Nanotheranostics. 5: 391-404. PMID 33912379 DOI: 10.7150/ntno.57675 |
0.785 |
|
2021 |
Ur Rehman F, Mazhar K, Malik A, Naz SS, Shah KU, Khan A, Khan S, Ahmed R, Qaisar S. Surface modified multifaceted nanocarriers for oral non-conventional cancer therapy; synthesis and evaluation. Materials Science & Engineering. C, Materials For Biological Applications. 123: 111940. PMID 33812575 DOI: 10.1016/j.msec.2021.111940 |
0.334 |
|
2020 |
Rehman FU, Al-Waeel M, Naz SS, Shah KU. Anticancer therapeutics: a brief account on wide refinements. American Journal of Cancer Research. 10: 3599-3621. PMID 33294257 |
0.335 |
|
2020 |
Rehman FU, Al-Waeel M, Naz SS, Shah KU. Anticancer therapeutics: a brief account on wide refinements. American Journal of Cancer Research. 10: 3599-3621. PMID 33294257 |
0.335 |
|
2020 |
Zafar N, Madni A, Khalid A, Khan T, Kousar R, Naz SS, Wahid F. Pharmaceutical and Biomedical Applications of Green Synthesized Metal and Metal Oxide Nanoparticles. Current Pharmaceutical Design. PMID 33243108 DOI: 10.2174/1381612826666201126144805 |
0.333 |
|
2017 |
Heckert B, Banerjee T, Sulthana S, Naz S, Alnasser R, Thompson D, Normand G, Grimm J, Perez JM, Santra S. Design and Synthesis of New Sulfur-Containing Hyperbranched Polymer and Theranostic Nanomaterials for Bimodal Imaging and Treatment of Cancer. Acs Macro Letters. 6: 235-240. PMID 29104818 DOI: 10.1021/acsmacrolett.7b00008 |
0.539 |
|
2017 |
Naz S, Beach J, Heckert B, Tummala T, Pashchenko O, Banerjee T, Santra S. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment. Nanomedicine (London, England). PMID 28181459 DOI: 10.2217/nnm-2016-0399 |
0.583 |
|
2017 |
Sulthana S, Banerjee T, Kallu J, Vuppala SR, Heckert B, Naz S, Shelby T, Yambem O, Santra S. Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria. Molecular Pharmaceutics. PMID 28081601 DOI: 10.1021/acs.molpharmaceut.6b01076 |
0.605 |
|
Show low-probability matches. |